行動心電遙測市場規模、佔有率和成長分析(按應用、類型和地區分類)—2026-2033年產業預測
市場調查報告書
商品編碼
1905922

行動心電遙測市場規模、佔有率和成長分析(按應用、類型和地區分類)—2026-2033年產業預測

Mobile Cardiac Telemetry Market Size, Share, and Growth Analysis, By Application (lead based, patch based), By Type (Hospitals, cardiac centres), By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球行動心電遙測市場規模預計在 2024 年達到 10.1 億美元,從 2025 年的 11.3 億美元成長到 2033 年的 28.2 億美元,在預測期(2026-2033 年)內複合年成長率為 12.1%。

行動心電遙測(MCT) 系統是攜帶式心臟監測領域的最尖端科技,可提供先進的即時分析,從而降低門診病人心電圖診斷的相關成本。這些小巧便攜的設備提高了病患和醫護人員的診療效率。心血管疾病 (CVD) 的日益普遍,以及 MCT 監測的許多益處,正在推動老齡化社會中市場的成長。心血管疾病涵蓋多種嚴重的心血管疾病,而吸煙和不良飲食等生活方式因素會進一步加劇患病風險,凸顯了有效監測解決方案的緊迫性。 MCT 系統利用患者佩戴的小型感測器,在發生心臟事件時傳輸數據以供即時分析。詳細的報告有助於醫生提高診斷準確性和治療管理水平。

全球行動心電遙測市場促進因素

全球行動心電遙測市場的成長主要得益於人們對創新貼片技術的認知不斷提高,以及應用更廣泛的新型設備的研發。這種認知的提升促使醫療服務提供者和患者更多地採用這些先進的解決方案,從而增強了監測能力並改善了患者的治療效果。隨著越來越多的醫療專業人員認知到移動心電遙測的優勢,對這些系統的需求持續成長,推動了技術進步,並拓展了市場機會。因此,這一上升趨勢正在重塑心臟監測和護理的未來模式。

限制全球移動心電遙測市場發展的因素

尖端行動心電遙測設備的高昂成本可能會阻礙其在醫療保健領域的廣泛應用。因此,此經濟障礙對全球移動心電遙測市場的擴張構成挑戰。這些先進系統的高昂價格限制了許多醫療機構的取得途徑,最終影響他們有效採用和利用此類技術的能力。因此,這項阻礙因素會減緩創新和應用的速度,影響行動心電遙測解決方案在各種醫療環境中的整體成長潛力。解決這些成本相關問題對於市場的發展至關重要。

全球行動心電遙測市場趨勢

全球行動心臟遙測市場呈現穩定上升趨勢,主要得益於技術進步,使得心臟監測更方便有效率。隨著醫療保健模式向以患者為中心的方向轉變,能夠為心臟病患者提供持續即時數據傳輸的行動系統需求激增。這些系統不僅提升了病患的活動能力,也能方便醫護人員及時進行醫療介入。行動心電遙測中先進分析和連接功能的整合進一步推動了市場成長,因為相關人員認知到遠端監測的價值,並認可其對改善患者預後和降低醫療成本的貢獻。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球行動心電遙測市場規模(按應用及複合年成長率分類)(2026-2033 年)

  • 主音貝斯
  • 基於補丁

全球行動心電遙測市場規模(按類型和複合年成長率分類)(2026-2033 年)

  • 醫院
  • 心臟中心
  • 其他

全球行動心電遙測市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Medtronic plc(Ireland)
  • Koninklijke Philips NV(Netherlands)
  • iRhythm Technologies, Inc.(USA)
  • Preventice Solutions(USA)
  • Boston Scientific Corporation(USA)
  • ScottCare Corporation(USA)
  • Applied Cardiac Systems, Inc.(USA)
  • Medicomp, Inc.(USA)
  • CardioNet, Inc.(USA)
  • LifeWatch AG(Switzerland)
  • Bittium Corporation(Finland)
  • GE Healthcare(USA)
  • Siemens Healthineers AG(Germany)
  • Hillrom Holdings, Inc.(USA)
  • Baxter International Inc.(USA)
  • AliveCor, Inc.(USA)
  • InfoBionic, Inc.(USA)

結論與建議

簡介目錄
Product Code: SQMIG35A2202

Global Mobile Cardiac Telemetry Market size was valued at USD 1.01 Billion in 2024 and is poised to grow from USD 1.13 Billion in 2025 to USD 2.82 Billion by 2033, growing at a CAGR of 12.1% during the forecast period (2026-2033).

Mobile Cardiac Telemetry (MCT) systems are at the forefront of ambulatory cardiac monitoring, offering advanced real-time analysis that lowers costs associated with electrocardiographic diagnosis for outpatients. These compact, portable devices enhance care efficiency for both patients and healthcare providers. The increasing prevalence of cardiovascular diseases (CVDs), alongside the benefits of MCT monitoring, fuels market growth, driven by an aging population. As CVDs encompass significant heart and blood vessel disorders, lifestyle factors such as tobacco use and poor diet further exacerbate risks, highlighting the urgent need for effective monitoring solutions. MCT systems utilize small sensors worn by patients, transmitting data for immediate analysis during cardiac events and improving diagnostic accuracy and therapeutic management through detailed reporting for physicians.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mobile Cardiac Telemetry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mobile Cardiac Telemetry Market Segments Analysis

Global Mobile Cardiac Telemetry Market is segmented by Application, Type and region. Based on Application, the market is segmented into lead based and patch based. Based on Type, the market is segmented into Hospitals, cardiac centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mobile Cardiac Telemetry Market

The growth of the global mobile cardiac telemetry market is being fueled by a heightened awareness of innovative patch technology and the development of new devices featuring enhanced applications. This awareness is encouraging both healthcare providers and patients to adopt these advanced solutions, thereby improving monitoring capabilities and fostering better patient outcomes. As more medical professionals recognize the benefits of mobile cardiac telemetry, the demand for these systems continues to rise, leading to advancements in technology and expanded opportunities within the market. Consequently, this upward trend is shaping the future landscape of cardiac monitoring and care.

Restraints in the Global Mobile Cardiac Telemetry Market

The significant expense associated with cutting-edge mobile cardiac telemetry devices can hinder their widespread adoption within the healthcare sector. As a result, this financial barrier poses a challenge to the expansion of the global mobile cardiac telemetry market. The high prices of these advanced systems may lead to limited accessibility for many healthcare providers, ultimately affecting their ability to implement and utilize such technologies effectively. Consequently, this restraint could slow down innovation and deployment, impacting the overall growth potential of mobile cardiac telemetry solutions in various healthcare settings. Addressing these cost-related issues will be crucial for market advancement.

Market Trends of the Global Mobile Cardiac Telemetry Market

The Global Mobile Cardiac Telemetry market is witnessing a robust upward trend driven by advancements in technology, which enhance the convenience and efficiency of cardiac monitoring. As healthcare shifts towards more patient-centric approaches, the demand for mobile systems that enable continuous, real-time data transmission for cardiology patients is surging. These systems not only empower patients with greater mobility but also facilitate timely medical interventions for healthcare providers. The integration of advanced analytics and connectivity in mobile cardiac telemetry is further propelling market growth, as stakeholders increasingly recognize the value of remote monitoring in improving patient outcomes and reducing healthcare costs.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Mobile Cardiac Telemetry Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • lead based
  • patch based

Global Mobile Cardiac Telemetry Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • cardiac centres
  • others

Global Mobile Cardiac Telemetry Market Size & CAGR (2026-2033)

  • North America (Application, Type)
    • US
    • Canada
  • Europe (Application, Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Application, Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Application, Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Application, Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Preventice Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScottCare Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Cardiac Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicomp, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioNet, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeWatch AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bittium Corporation (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hillrom Holdings, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AliveCor, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InfoBionic, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations